Benzodiazepines for the relief of breathlessness in malignant and advanced non-malignant diseases in adults

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Simon, Steffen ^a   Bausewein, Claudia ^b   Booth, Sara ^c   Harding, Richard ^b   Higginson, Irene J ^b  

^a Institute of Palliative Care   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG EFFICACY; DYSPNEA; FIBROSING ALVEOLITIS; HEART FAILURE; HUMAN; MOTOR NEURON DISEASE; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 55049138383     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007354     Document Type: Review

References (19)

1. ATS 1999 American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Journal of Respiratory and Critical Care Medicine 1999;159:321-40.
2. Bausewein 2008 Bausewein C, Booth S, Gysels M, Higginson IJ. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005623.pub2]
3. Beach 2006 Beach D, Schwartzstein RM. The genesis of breathlessness - What do we understand?. Booth S, Dudgeon D (Eds): Dyspnoea in advanced disease - a guide to clinical management. First Edition. Oxford University Press, Oxford, 2006:1-18.
4. Booth 2006 Booth S, Dudgeon D. Dyspnoea in advanced disease - a guide to clinical management. First Edition. Oxford University Press, Oxford, 2006.
5. Booth 2008 Booth S, Moosavi SH, Higginson IJ. The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nature Clinical Practice Oncology 2008;5:90-100.
6. Bruera 2006 Bruera E, Higginson IJ, Robb SD, von Gunten CF. Textbook of Palliative Medicine. First Edition. Hodder Arnold, London, 2006.
7. Davis 2005 Davis C. Drug therapies. Ahmedzai SH, Muers MF (eds): Supportive Care in Respiratory Disease. First Edition. Oxford University Press, Oxford, 2005:147-63.
8. Edwards 2000 Edwards A, Hood K, Matthews E, Russell D, Russell I, Barker J, et al.The effectiveness of one-to-one risk communication interventions in health care: a systematic review. Medical Decision Making 2000;20:290-7.
9. GOLD 2007 Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD (2007). Download 31.01.2008. Available from: http://www.goldcopd.org.
10. Hardman 2005 Hardman JG, Limbird LE. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th Edition. McGraw-Hill, New York, 2005.
11. Higgins 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0. The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2008 [updated February 2008].
12. Higginson 2004 Higginson IJ, Addington-Hall J. The epidemiology of death and symptoms. Doyle D, Hanks G, Cherny N, Calman K (eds): Oxford Textbook of Palliative Medicine. Third Edition. Oxford University Press, Oxford, 2004:14-24.
13. Jennings 2001 Jennings AL, Davies AN, Higgins JP, Broadley K. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858. CD002066]
14. Manning 1995 Manning HL, Schwartzstein RM. Pathophysiology of dyspnea. New England Medical Journal 1995;333:1547-53.
15. Muers 1993 Muers MF, Round CE. Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax 1993;48:339-43.
16. Neumann 2006 Neuman A, Gunnbjornsdottir M, Tunsater A, Nystrom L, Franklin KA, Norrman E, et al.Dyspnea in relation to symptoms of anxiety and depression: A prospective population study. Respiratory Medicine 2006;100:1843-9.
17. Nordgren 2003 Nordgren L, Sorensen S. Symptoms experienced in the last six months of life in patients with end-stage heart failure. European Journal of Cardiovascular Nursing 2003;2:213-7.
18. Solano 2006 Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. Journal of Pain and Symptom Management 2006;31:58-69.
19. Uronis 2008 Uronis HE, Abernethy AP. Oxygen for relief of dyspnea: what is the evidence?. Current Opinion in Supportive and Palliative Care 2008;2(2):89-94.